Promising collaboration to revolutionize CKD treatment

We are delighted to announce that our NephroGuard project has been selected as one of the experimental projects of Tiers-lieu Unirein, a consortium of excellence bringing together the best experts in the field of kidney disease. This collaboration marks an important step forward in our mission to optimize the management of CKD thanks to the innovative digital solutions developed by Bio Logbook.

Unirein: A catalyst for innovation in kidney disease

The Tiers-lieu Unirein is an ambitious initiative aimed at transforming the management of renal and metabolic diseases in France. This unique hub brings together key players in the sector, such as researchers, clinicians, manufacturers and patients, around a common goal: to accelerate the development and adoption of innovative solutions to improve the quality of life of CKD patients.

NephroGuard: A digital solution for patients

NephroGuard is a digital solution designed to support CKD patients in their care. This intuitive platform enables patients to track their health status in real time, receive personalized advice and connect with their medical team. NephroGuard has already demonstrated its effectiveness in improving patient health outcomes and reducing healthcare costs.

A promising collaboration for the future

Our participation in the Tiers-lieu Unirein will enable us to benefit from an environment conducive to innovation, and to collaborate closely with world-renowned experts. We are convinced that this collaboration will accelerate the development of NephroGuard and make it a key solution for the management of CKD in France.

A revolutionary patented methodology

The study, entitled " A novel methodology for calculating optimized and personalized reference populations of biological parameters", presents a patented methodology developed by Bio Logbook for calculating optimized and personalized reference populations of biological parameters. This innovative methodology enables more accurate and relevant results to be obtained for patient diagnosis and follow-up, paving the way for more personalized, high-performance medicine.

Recognized scientific impact

The publication of this study in CCA Clinica Chimica Acta, a leading scientific journal in the field of clinical chemistry, testifies to the quality and scientific impact of Bio Logbook's work. This international recognition positions the company as a major player in the development of innovative solutions to improve patient care.

Tribute to contributors

Ronan Boutin, President and Founder of Bio Logbook, would like to express his deep gratitude to all the people and institutions who have contributed to this success:

INOVIE (Groupe), and in particular Dr Bruno Gauthier and Dr Pierre-Jean Lamy, for their invaluable contribution.

CHU de Liège: Pr. Philippe Kolh, Pr. Michel Moutschen; Dr. Nathalie Maes, Marie Thys_Marie

Prof. ALBERT Adelin for his invaluable support and patience.

Clément Bézier for his excellent editorial work and fine-tuning of the publication.

Jakez Rolland and Marie Codet for their proofreading and production of analyses and graphs.

A new milestone

The publication of this scientific study marks a new milestone for Bio Logbook. The company is determined to pursue its research and develop new innovative solutions to improve patient health.

"This publication is an important milestone for Bio Logbook," says Ronan Boutin. "It confirms the scientific value of our work and encourages us to continue our efforts to develop innovative solutions that contribute to improving patient care."

Fruitful meetings with key players in healthcare and AI

During this mission, Bio Logbook had the honor of meeting key players in the healthcare and AI fields in Quebec, including researchers, clinicians, entrepreneurs and representatives of public institutions. These meetings were an opportunity for the company to present its innovative solutions in biological data analysis and artificial intelligence, and aroused keen interest among participants.

Enriching exchanges on health issues

The meetings organized as part of the Mission Collective also enabled Bio Logbook to compare the challenges faced by healthcare players in Quebec and France, particularly in terms of medical data management and the use of artificial intelligence. These enriching exchanges enabled the company to better understand the needs and challenges of the Quebec market, and to adapt its approach accordingly.

A strong commitment to research and innovation

Bio Logbook was particularly moved by the commitment and passion of the researchers and professionals it met in Quebec. The company shares this commitment and reaffirms its ambition to help improve patient health through innovative solutions based on artificial intelligence.

A new stage in Bio Logbook's international expansion

A customized support program

The French Healthcare BOOSTER GERMANY 2024 will enable us to benefit from 9 months of tailor-made support. During this program, we will have access to :

• Individual support from coaches and experts in the German market.
• Training courses and workshops to better understand the German market and the specificities of its healthcare system.
• Connections with potential partners, such as investors, customers and institutional players.

A springboard for international business

We are convinced that the French Healthcare BOOSTER GERMANY 2024 will be a valuable springboard for our development in Germany. This program will enable us to :

• Accelerate our international growth.
• Strengthen our presence in the German market, one of the largest in Europe.
• Identify new partnership and collaboration opportunities.

We're proud to be part of this adventure alongside other innovative companies in the healthcare sector.

Together, we'll be helping to promote French know-how in Germany and improve patient health.

Find out more about the program and the winners

Data characterization: a crucial issue for healthcare

Data analysis and interpretation are at the heart of many scientific fields, and healthcare is no exception. To fully exploit the potential of biological and medical data, it is essential to characterize them accurately and thoroughly. This is the background to Jakez Rolland's work.

Topology, geometry and multidimensional structure: an innovative approach

In his research paper, Jakez Rolland proposes an innovative approach to characterizing data based on its topology, geometry and multidimensional structure. This approach captures valuable information on the relationships and interactions between data, opening up new perspectives for the analysis and interpretation of biological and medical data.

Towards more personalized medicine and unrivalled predictive capabilities

The potential applications of this approach are numerous and promising. In particular, it could contribute to the development of more accurate diagnostic and prognostic models, the identification of relevant biomarkers for patient management, and the development of personalized therapies.

Thanks to the thesis supervisors

Bio Logbook would like to warmly thank Benoit Delahaye and Damien Eveillard, the supervisors of Jakez Rolland's thesis, for their invaluable support and essential contribution to this research work.

A new milestone in healthcare innovation

We are proud to announce that Bio Logbook has been selected by the Pays de la Loire Region as part of its international gas pedal program dedicated to innovative healthcare. This selection represents a major recognition of our expertise in digital solutions for clinical trial management, and of our strong growth potential on international markets.

Tailor-made support for a successful internationalization strategy

For 18 months, we'll be receiving tailor-made support from TEAM FRANCE EXPORT PAYS DE LA LOIRE, ALTIOS International and Katalyse, all recognized experts in international business support.

This support program will enable us to :

• Access specific financing and assistance to support our international growth.
• Define and refine our international development strategy by identifying the most promising markets and adapting our offering to the specific needs of each country.
• Benefit from a network of experts and partners to facilitate our international expansion and forge strategic partnerships.

A strong commitment to ethical and responsible AI.

AI's Human Guarantee: a crucial issue

In the context of a proliferation of AI-based software in many fields, the question of AI's human guarantee is becoming a crucial issue, particularly in the sensitive field of healthcare. It is indeed essential to ensure that these technologies are developed and used ethically and responsibly, taking into account human and societal aspects.

An innovative approach at the heart of medical biology

That's why, at BioLogbook, we've chosen to take an innovative approach to AI by subscribing to the principles of the AI Human Guarantee. In collaboration with Ethik IA, a consultancy specializing in the ethics of artificial intelligence, and SFIL, we have set up a pilot project aimed at guaranteeing permanent human supervision of our AI software dedicated to medical biology.

An exemplary partnership in the service of ethics

This pilot project is part of an exemplary partnership between BioLogbook, Ethik IA and SFIL. We would like to extend our warmest thanks to the Ethik IA team, and in particular David Gruson and Emilie SENEGAS, for their invaluable expertise and commitment. We would also like to thank Eric LAINE, Chairman of SFIL, and the entire SFIL team, in particular Manuela MÉMIN and Bruno Gauthier, for their support and active collaboration.

A strong commitment to the future

The launch of this pilot project marks an important step in our commitment to ethical and responsible AI in medical biology. We are convinced that the AI Human Guarantee is an essential element in guaranteeing the trust and safety of patients and healthcare professionals.

We will continue to work actively with our partners to advance the responsible use of AI in healthcare, contributing to better, more humane medicine.

Bio Logbook Healthcare: An innovative solution for more precise and personalized medical biology

Bio Logbook Healthcare is a software solution based on artificial intelligence that enhances the accuracy and personalization of medical biology examinations. Thanks to this solution, doctors can access more complete and relevant information for diagnosing and monitoring their patients. Bio Logbook Healthcare also helps reduce waiting times and costs for biological analyses.

A constructive exchange with the Délégation ministérielle au Numérique en Santé (Ministerial Delegation for Digital Health)

Exchanges between Bio Logbook teams and DNS were rich and constructive. Both parties were able to share their respective visions of digital healthcare and discuss the challenges facing the sector. DNS was also impressed by Bio Logbook Healthcare's innovation, and praised the solution's potential to improve patient care.

Bio Logbook, a committed player in the transformation of digital healthcare

Bio Logbook is committed to the transformation of digital healthcare. The company is convinced that digital technology has the potential to revolutionize this sector and contribute to more efficient medicine that is more accessible to all. Bio Logbook is proud to be part of this transformation, and to collaborate with public and private players to make digital healthcare a lever for improving patient health.

A major recognition of our expertise in innovation.

An enthusiastic welcome for our technology

Our solution received a particularly enthusiastic welcome from participants and the GISEH organization. Our presentation, which focused on the impact of new technologies and artificial intelligence on healthcare organizations, was much appreciated, and prompted numerous questions and discussions.

An award that reinforces our commitment

This award is a major recognition of our expertise in innovation and our commitment to developing high-performance, useful digital solutions for the healthcare sector. It also confirms our choice to focus on the development of solutions based on artificial intelligence, which have the potential to revolutionize patient care and the organization of healthcare systems.

Thanks to our partners and collaborators

We would like to extend our warmest thanks to all those who contributed to this success, in particular the CHU de Liège, with whom we will be working closely from 2019. We would also like to thank the organizers of GISEH for organizing this high-quality event and for the recognition they have given our innovation.

A promising future

This award encourages us to continue our efforts to innovate and develop new digital solutions to improve patient health. We are convinced that artificial intelligence has the potential to transform the healthcare sector, and we are proud to be part of this adventure.

Promising collaboration to revolutionize CKD treatment

Bio Logbook is a Nantes-based start-up developing an innovative statistical methodology to improve medical diagnosis. Founded in 2018 by Ronan Boutin, a physics engineer, the company relies on the concept of "drift" to anticipate the occurrence of chronic and low-noise diseases.

Bio Logbook's technology enables doctors to identify at-risk patients earlier and better understand complex diseases. This can lead to earlier interventions, better patient care and reduced healthcare costs.

Partnerships with key players in the healthcare sector

Bio Logbook works with leading university hospitals (CHU) and research laboratories to collect data and develop its algorithms. The company is also an active member of the Les Deeptech community, a Bpifrance initiative supporting French deeptech start-ups.

A promising future for Bio Logbook

Bio Logbook has already raised funds and plans to double its workforce by 2024. The company is also developing a beta test to detect those most at risk of developing a severe form of Covid-19.

Read the full article here